Bharat Biotech vaccine | Zee News

Advertisement

NewsBharat Biotech vaccine

Bharat Biotech vaccine News

22 Jan 2023

The country's first Nasal Corona vaccine launches on Republic Day

Nasal Covid-19 Vaccine: The first intranasal Covid-19 vaccine 'Incovac' developed in the country will be started from January 26. It has been made by Swadeshi Bharat Biotech.

nasal vaccine covid bharat biotech

06 Sep 2022

DCGI approves Corona's Nasal Vaccine

Another vaccine has been approved in the war against the corona epidemic. DCGI has approved Bharat Biotech's nasal vaccine for Corona. This will be the country's first nasal vaccine.

23 Jul 2021

AIIMS Delhi to start second dose trial of Covaxin on 2-6 years by next week

Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week. The first trial was started in the age group of 12-18 years followed by the age group of 6-12 years and 2-6 years which are currently undergoing trials.

12 Jun 2021

COVID-19: Bharat Biotech ready for Covaxin's clinical trial in US

The full data from studies on Covaxin's neutralisation of variants are already published.

27 Feb 2021

People with THESE health conditions will get COVID-19 vaccine jabs on priority

In the third phase of the coronavirus vaccination drive which begins from March 1, the government is aiming to expand the vaccination drive to the general public of the nation. People with co-morbid conditions will need to carry a medical certificate to receive the vaccination.

27 Feb 2021

For COVID-19 vaccine in private hospital this is how much you may have to pay

NITI Aayog has promulgated a price range of Rs 300-500 which the private hospitals can charge for the two COVID-19 vaccines. The government has been procuring SII's Covishield for around Rs 210 per dose while the cost of Covaxin is around Rs 290 for a shot.

27 Feb 2021

COVID-19 vaccine price between Rs 300-500, proposes NITI Aayog

The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities. In the third phase of vaccination set to begin from March 1 Covid vaccines will be available in private hospitals as well.

10 Feb 2021

Bharat Biotech to pay compensation if Covaxin causes side effects

In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals. The compensation for the serious adverse event will be paid by the sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in the public interest as an abundant caution, in clinical trial mod

12 Jan 2021

COVID vaccine rollout: First consignment of Covishield reaches Delhi, Gujarat

A SpiceJet flight carrying the vaccines landed at the Delhi airport around 10 am. Civil Aviation Minister Hardeep Singh Puri said four airlines will operate nine flights to transport the vaccine. A 'puja' was performed before the vehicles left the facility.

03 Jan 2021

PM Modi hails DCGI vaccine nod, says 'move will lead to COVID-free nation'

DCGI on Sunday approved Covishield and Covaxin for restricted use in India. Covaxin is developed by Bharat Biotech. Serum Intitute and Bharat Biotech vaccines have to be administered in two doses.

03 Jan 2021

COVID-19: Serum, Bharat Biotech vaccines get DCGI approval for emergency use

DCGI on Sunday approved Covishield and Covaxin for restricted use in India. Covaxin is developed by Bharat Biotech. Serum Intitute and Bharat Biotech vaccines have to be administered in two doses.

Loading...

NEWS ON ONE CLICK